• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TNFAIP8L3对转化生长因子-β信号通路的调控在肿瘤抗原呈递过程中影响巨噬细胞比例,并影响卵巢癌的预后。

TNFAIP8L3 regulation of the TGF-β signaling pathway affects the proportion of macrophages during tumor antigen presentation and affects the prognosis of ovarian cancer.

作者信息

Yue Chaomin, Zheng Xiao, Ye Yuqing, Li Danyang, Zhou Yanhong

机构信息

Department of Obstetrics and Gynaecology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.

Department of General Surgery, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

出版信息

Front Mol Biosci. 2025 Apr 24;12:1566363. doi: 10.3389/fmolb.2025.1566363. eCollection 2025.

DOI:10.3389/fmolb.2025.1566363
PMID:40343258
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12058474/
Abstract

BACKGROUND

Ovarian cancer is a serious disease that is a danger to a woman's life and health and is currently being extensively studied worldwide. TNFAIP8L3, a member of the tumor necrosis family, plays a significant role in tumor immune regulation; however, its role in ovarian cancer has not been fully studied and reported.

METHOD

This study used data from 381 cases of ovarian cancer (OVCA) from The Cancer Genome Analysis (TCGA)-OV to analyze the clinical phenotype and immune phenotype of TNFAIP8L3. Pearson correlation coefficients and protein-protein interaction (PPI) network analyses were used to identify potential biological functions and the genes co-expressed with TNFAIP8L3. The Gene Set Enrichment Analysis (GSEA) method was used to evaluate the relevant regulatory pathways of TNFAIP8L3. Gene Set Variation Analysis was performed to evaluate the proportions of 24 immune cell types in OVCA. Finally, a nomogram and multivariate COX regression analysis were performed to prove the independent prognostic value of TNFAIP8L3 in OVCA.

RESULTS

A total of 181 genes were co-expressed with TNFAIP8L3, including 163 positively correlated and 18 negatively correlated genes. The co-expressed genes associated with TNFAIP8L3 were significantly enriched in biological processes such as cell activation involved in immune response and leukocyte activation involved in immune response. Pathway analysis of TNFAIP8L3 further revealed the association of TNFAIP8L3 with the TGF-β signaling pathway and antigen processing and presentation pathways, especially with macrophages and neutrophils in the antigen presentation process. Moreover, the expression of TNFAIP8L3 was significantly high in OVCA and other solid tumors to function as an independent risk factor for the prognosis of OVCA, with important research value for the prognosis of patients with OVCA.

CONCLUSION

Those findings indicate that TNFAIP8L3 is correlated with antigen processing and presentation pathways in macrophages and neutrophils and affects prognosis and immune infiltration in OVCA.

摘要

背景

卵巢癌是一种严重威胁女性生命健康的疾病,目前正在全球范围内进行广泛研究。肿瘤坏死因子家族成员TNFAIP8L3在肿瘤免疫调节中发挥重要作用;然而,其在卵巢癌中的作用尚未得到充分研究和报道。

方法

本研究使用来自癌症基因组分析(TCGA)-卵巢癌(OV)的381例卵巢癌(OVCA)数据,分析TNFAIP8L3的临床表型和免疫表型。采用Pearson相关系数和蛋白质-蛋白质相互作用(PPI)网络分析来确定潜在的生物学功能以及与TNFAIP8L3共表达的基因。使用基因集富集分析(GSEA)方法评估TNFAIP8L3的相关调控途径。进行基因集变异分析以评估OVCA中24种免疫细胞类型的比例。最后,构建列线图并进行多变量COX回归分析,以证明TNFAIP8L3在OVCA中的独立预后价值。

结果

共有181个基因与TNFAIP8L3共表达,其中163个呈正相关,18个呈负相关。与TNFAIP8L3共表达的基因在免疫反应中涉及的细胞活化和免疫反应中涉及的白细胞活化等生物学过程中显著富集。TNFAIP8L3的通路分析进一步揭示了TNFAIP8L3与TGF-β信号通路以及抗原加工和呈递通路的关联,特别是在抗原呈递过程中与巨噬细胞和中性粒细胞的关联。此外,TNFAIP8L3在OVCA和其他实体瘤中的表达显著升高,可作为OVCA预后的独立危险因素,对OVCA患者的预后具有重要研究价值。

结论

这些发现表明TNFAIP8L3与巨噬细胞和中性粒细胞中的抗原加工和呈递通路相关,并影响OVCA的预后和免疫浸润。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4dc/12058474/c7c592b6a38b/fmolb-12-1566363-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4dc/12058474/d38092b384ed/fmolb-12-1566363-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4dc/12058474/7297d622104a/fmolb-12-1566363-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4dc/12058474/582fbeecf278/fmolb-12-1566363-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4dc/12058474/fd40618dd6e3/fmolb-12-1566363-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4dc/12058474/c7c592b6a38b/fmolb-12-1566363-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4dc/12058474/d38092b384ed/fmolb-12-1566363-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4dc/12058474/7297d622104a/fmolb-12-1566363-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4dc/12058474/582fbeecf278/fmolb-12-1566363-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4dc/12058474/fd40618dd6e3/fmolb-12-1566363-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4dc/12058474/c7c592b6a38b/fmolb-12-1566363-g005.jpg

相似文献

1
TNFAIP8L3 regulation of the TGF-β signaling pathway affects the proportion of macrophages during tumor antigen presentation and affects the prognosis of ovarian cancer.TNFAIP8L3对转化生长因子-β信号通路的调控在肿瘤抗原呈递过程中影响巨噬细胞比例,并影响卵巢癌的预后。
Front Mol Biosci. 2025 Apr 24;12:1566363. doi: 10.3389/fmolb.2025.1566363. eCollection 2025.
2
Novel LncRNA ZFHX4-AS1 as a Potential Prognostic Biomarker That Affects the Immune Microenvironment in Ovarian Cancer.新型长链非编码RNA ZFHX4-AS1作为一种潜在的预后生物标志物,影响卵巢癌的免疫微环境。
Front Oncol. 2022 Jul 12;12:945518. doi: 10.3389/fonc.2022.945518. eCollection 2022.
3
Systematic analysis reveals a lncRNA-mRNA co-expression network associated with platinum resistance in high-grade serous ovarian cancer.系统分析揭示了与高级别浆液性卵巢癌铂类耐药相关的 lncRNA-mRNA 共表达网络。
Invest New Drugs. 2018 Apr;36(2):187-194. doi: 10.1007/s10637-017-0523-3. Epub 2017 Oct 30.
4
Expression of tumor-associated macrophages and PD-L1 in patients with hepatocellular carcinoma and construction of a prognostic model.肿瘤相关巨噬细胞和 PD-L1 在肝癌患者中的表达及预后模型的构建。
J Cancer Res Clin Oncol. 2023 Sep;149(12):10685-10700. doi: 10.1007/s00432-023-04949-y. Epub 2023 Jun 12.
5
Identification of three molecular subtypes based on immune infiltration in ovarian cancer and its prognostic value.基于免疫浸润的卵巢癌三种分子亚型的鉴定及其预后价值。
Biosci Rep. 2020 Oct 30;40(10). doi: 10.1042/BSR20201431.
6
Identification of potential key genes of TGF-beta signaling associated with the immune response and prognosis of ovarian cancer based on bioinformatics analysis.基于生物信息学分析鉴定与卵巢癌免疫反应和预后相关的转化生长因子-β信号通路潜在关键基因
Heliyon. 2023 Aug 19;9(8):e19208. doi: 10.1016/j.heliyon.2023.e19208. eCollection 2023 Aug.
7
A Neutrophil Extracellular Traps-Related Signature Predicts Clinical Outcomes and Identifies Immune Landscape in Ovarian Cancer.一种与中性粒细胞胞外诱捕网相关的特征可预测卵巢癌的临床结局并识别其免疫格局。
J Cell Mol Med. 2024 Dec;28(24):e70302. doi: 10.1111/jcmm.70302.
8
MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.MCM10 作为一种新型的预后生物标志物及其与胶质瘤免疫浸润的相关性。
Technol Health Care. 2023;31(4):1301-1317. doi: 10.3233/THC-220576.
9
Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.TYROBP 表达升高预示低级别胶质瘤患者预后不良和肿瘤免疫浸润程度高。
BMC Cancer. 2021 Jun 23;21(1):723. doi: 10.1186/s12885-021-08456-6.
10
NLRP12 is a prognostic biomarker and correlated with immune infiltrates in epithelial ovarian cancer.NLRP12 是上皮性卵巢癌的预后生物标志物,并与免疫浸润相关。
J Gene Med. 2024 Jan;26(1):e3585. doi: 10.1002/jgm.3585. Epub 2023 Nov 5.

本文引用的文献

1
The Application of Dendritic Cells Vaccines in Tumor Therapy and Their Combination with Biomimetic Nanoparticles.树突状细胞疫苗在肿瘤治疗中的应用及其与仿生纳米颗粒的联合应用
Vaccines (Basel). 2025 Mar 21;13(4):337. doi: 10.3390/vaccines13040337.
2
Combination autologous stem cell transplantation with chimeric antigen receptor T-cell therapy for refractory/relapsed B-cell lymphoma: a single-arm clinical study.嵌合抗原受体T细胞疗法联合自体干细胞移植治疗难治性/复发性B细胞淋巴瘤:一项单臂临床研究
Front Immunol. 2025 Feb 26;16:1532460. doi: 10.3389/fimmu.2025.1532460. eCollection 2025.
3
γδ T Cell-mediated Tumor Immunity is Tightly Regulated by STING and TGF-β Signaling Pathways.
γδ T细胞介导的肿瘤免疫受到STING和TGF-β信号通路的严格调控。
Adv Sci (Weinh). 2025 Jan;12(2):e2404432. doi: 10.1002/advs.202404432. Epub 2024 Nov 21.
4
Emerging strategies to overcome ovarian cancer: advances in immunotherapy.克服卵巢癌的新兴策略:免疫疗法的进展
Front Pharmacol. 2024 Nov 5;15:1490896. doi: 10.3389/fphar.2024.1490896. eCollection 2024.
5
An umbrella review of meta-analyses regarding the incidence of female-specific malignancies after fertility treatment.一项关于生育治疗后女性特定恶性肿瘤发病率的荟萃分析的伞状综述。
Fertil Steril. 2025 Mar;123(3):506-519. doi: 10.1016/j.fertnstert.2024.09.023. Epub 2024 Nov 14.
6
Utilization of miRNAs as Biomarkers for the Diagnosis, Prognosis, and Metastasis in Gynecological Malignancies.利用 miRNA 作为妇科恶性肿瘤诊断、预后和转移的生物标志物。
Int J Mol Sci. 2024 Oct 31;25(21):11703. doi: 10.3390/ijms252111703.
7
Surgical Management of Gynecologic Cancers.妇科癌症的外科治疗。
Hematol Oncol Clin North Am. 2025 Feb;39(1):67-87. doi: 10.1016/j.hoc.2024.08.013.
8
The Role of Tumor Biomarkers in Tailoring the Approach to Advanced Ovarian Cancer.肿瘤标志物在制定晚期卵巢癌治疗策略中的作用。
Int J Mol Sci. 2024 Oct 19;25(20):11239. doi: 10.3390/ijms252011239.
9
Exploring the correlation between periodontal disease and serum biomarkers in haemodialysis patients.探讨血液透析患者牙周病与血清生物标志物的相关性。
BMC Oral Health. 2024 Sep 11;24(1):1066. doi: 10.1186/s12903-024-04826-1.
10
TIPE2 inhibits the migration and invasion of epithelial ovarian cancer cells by targeting Smad2 to reverse TGF-β1-induced EMT.TIPE2 通过靶向 Smad2 逆转 TGF-β1 诱导的 EMT 抑制上皮性卵巢癌细胞的迁移和侵袭。
FASEB J. 2024 Sep;38(17):e70045. doi: 10.1096/fj.202401427R.